$RLFTF (copy) y5h--00 Big Rock Partners Acquisitio
Post# of 653
(Total Views: 580)
Posted On: 01/27/2021 6:21:44 PM
$RLFTF (copy) y5h--00 Big Rock Partners Acquisition Corp. FORM S-4
Released: January 27, 2021
Page: 173
https://fintel.io/doc/sec-big-rock-partners-a...27-18654-7
Our first VIP-derived product - ZYESAMI (RLF-100), the NeuroRx COVID-19 Drug - was awarded Fast Track designation by the FDA in June 2020 and admitted to the Coronavirus Treatment Acceleration Program. NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021.
With news from Gilles della Corte as well. We should see data very very soon.
Released: January 27, 2021
Page: 173
https://fintel.io/doc/sec-big-rock-partners-a...27-18654-7
Our first VIP-derived product - ZYESAMI (RLF-100), the NeuroRx COVID-19 Drug - was awarded Fast Track designation by the FDA in June 2020 and admitted to the Coronavirus Treatment Acceleration Program. NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021.
With news from Gilles della Corte as well. We should see data very very soon.
(1)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
Scroll down for more posts ▼